New strategies for curing diseases not only require safe and efficient drugs, but also an evaluation of how these drugs can be best administered to patients. Protein therapeuticals have the advantage of being very specific, but denaturation and high molecular masses are two examples of factors that need to be considered in their delivery.
展开▼
